Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Isoamyl acetate-hydrolyzing esterase 1 (IAH1) is an enzyme classified as a carboxylic-ester hydrolase that catalyzes the hydrolysis of short-chain esters, specifically from acetate (C2) up to hexanoate (C6). Its activity is best described in yeast (Saccharomyces cerevisiae), where it hydrolyzes isoamyl acetate, an ester contributing to fruity aroma. In humans, IAH1 is a protein-coding gene with predicted hydrolase activity, likely involved in lipid catabolic processes through its action on ester bonds. Disease associations include certain inflammatory and metabolic disorders, but it is not currently established as a therapeutic or drug-targeted protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Isoamyl acetate-hydrolyzing esterase 1 (IAH1).